{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:05:59Z","timestamp":1791378359648,"version":"4.3.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12328-026-02385-2","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T05:51:26Z","timestamp":1782021086000},"page":"1215-1221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multidisciplinary treatment with durvalumab-containing regimens for mixed neuroendocrine\u2013non-neuroendocrine neoplasm of the extrahepatic bile duct"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1941-9074","authenticated-orcid":false,"given":"Yuto","family":"Kitano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kento","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiharu","family":"Tokimitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,21]]},"reference":[{"key":"2385_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76:182\u20138.","journal-title":"Histopathology"},{"key":"2385_CR2","unstructured":"Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. World Health Organization; 2010."},{"key":"2385_CR3","unstructured":"Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumors of the digestive system. World Health Organization; 2017."},{"key":"2385_CR4","first-page":"341","volume":"19","author":"K Tsalis","year":"2010","unstructured":"Tsalis K, Vrakas G, Geroukis T, et al. Primary neuroendocrine tumor of the extrahepatic biliary tree mimicking Klatskin tumor. J Gastrointest Liver Dis. 2010;19:341\u20132.","journal-title":"J Gastrointestin Liver Dis"},{"key":"2385_CR5","volume-title":"TNM classification of malignant tumors","author":"JD Brierley","year":"2016","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumors. 8th ed. Hoboken (NJ): Wiley-Blackwell; 2016.","edition":"8"},{"key":"2385_CR6","doi-asserted-by":"publisher","first-page":"EVIDoa2200015","DOI":"10.1056\/EVIDoa2200015","volume":"1","author":"DY Oh","year":"2022","unstructured":"Oh DY, Ruth He A, Qin S, et al. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. NEJM Evid. 2022;1:EVIDoa2200015.","journal-title":"NEJM Evid"},{"key":"2385_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347.","journal-title":"Eur J Cancer"},{"key":"2385_CR8","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/archsurg.1992.01420110083017","volume":"127","author":"DB Evans","year":"1992","unstructured":"Evans DB, Rich TA, Byrd DR, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg. 1992;127:1335\u20139.","journal-title":"Arch Surg"},{"key":"2385_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00428-012-1212-4","volume":"460","author":"K Harada","year":"2012","unstructured":"Harada K, Sato Y, Ikeda H, et al. Clinicopathologic study of mixed adenoneuroendocrine carcinomas of hepatobiliary organs. Virchows Arch. 2012;460:281\u20139.","journal-title":"Virchows Arch"},{"key":"2385_CR10","first-page":"1841","volume":"28","author":"T Ito","year":"2016","unstructured":"Ito T, Nakamura A, Kitano M, et al. The diagnosis of neuroendocrine tumor of the gallbladder and bile duct. Shokakinaishikyo. 2016;28:1841\u20137. (in Japanese).","journal-title":"Shokakinaishikyo"},{"key":"2385_CR11","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s12253-014-9808-4","volume":"20","author":"N Michalopoulos","year":"2014","unstructured":"Michalopoulos N, Papavramidis TS, Karayannopoulou G, et al. Neuroendocrine tumors of extrahepatic biliary tract. Pathol Oncol Res. 2014;20:765\u201375.","journal-title":"Pathol Oncol Res"},{"key":"2385_CR12","first-page":"8218","volume":"8","author":"C Chen","year":"2015","unstructured":"Chen C, Wang L, Liu X, et al. Gallbladder neuroendocrine carcinoma: report of 10 cases and comparision of clinicopathologic features with gallbladder adenocarcinoma. Int J Clin Exp Pathol. 2015;8:8218\u201326.","journal-title":"Int J Clin Exp Pathol"},{"key":"2385_CR13","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","volume":"401","author":"RK Kelley","year":"2023","unstructured":"Kelley RK, Ueno M, Yoo C, et al. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023;401:1853\u201365.","journal-title":"Lancet"},{"key":"2385_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/jhbp.1219","volume":"30","author":"T Ioka","year":"2023","unstructured":"Ioka T, Kanai M, Kobayashi S, et al. Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401-MITSUBA). J Hepatobiliary Pancreat Sci. 2023;30:102\u201310.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"2385_CR15","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.21873\/invivo.13974","volume":"39","author":"Y Tagayasu","year":"2025","unstructured":"Tagayasu Y, Yamada R, Kanemitsu K, et al. Conversion surgery performed following durvalumab combined with gemcitabine and cisplatin in cholangiocarcinoma: a case report. Vivo. 2025;39:1724\u201330.","journal-title":"Vivo"},{"key":"2385_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12328-024-02084-w","volume":"18","author":"T Nakayama","year":"2025","unstructured":"Nakayama T, Nakano H, Matsushita R, et al. Pathological complete response after chemotherapy in initially unresectable distal cholangiocarcinoma. Clin J Gastroenterol. 2025;18:357\u201362.","journal-title":"Clin J Gastroenterol"},{"key":"2385_CR17","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1001\/jamaoncol.2022.3395","volume":"8","author":"C Morizane","year":"2022","unstructured":"Morizane C, Machida N, Honma Y, et al. Effectiveness of etoposide and cisplatin vs irinotecan and cisplatin therapy for patients with advanced neuroendocrine carcinoma of the digestive system: the TOPIC-NEC phase 3 randomized clinical trial. JAMA Oncol. 2022;8:1447\u201355.","journal-title":"JAMA Oncol"},{"key":"2385_CR18","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1177\/1066896915580433","volume":"23","author":"AM Acosta","year":"2015","unstructured":"Acosta AM, Hamedani FS, Kajdacsy-Balla A, et al. Primary mixed adenoneuroendocrine carcinoma of the gallbladder in a 55-year-old female patient: a case report and review of the literature. Int J Surg Pathol. 2015;23:414\u20138.","journal-title":"Int J Surg Pathol"},{"key":"2385_CR19","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/MPA.0b013e3181ebb56f","volume":"39","author":"JR Strosberg","year":"2010","unstructured":"Strosberg JR, Coppola D, Klimstra DS, et al. The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas. Pancreas. 2010;39:799\u2013800.","journal-title":"Pancreas"},{"key":"2385_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/annonc\/mds276","volume":"24","author":"H Sorbye","year":"2013","unstructured":"Sorbye H, Welin S, Langer SW, et al. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHOG3): the NORDIC NEC study. Ann Oncol. 2013;24:152\u201360.","journal-title":"Ann Oncol"},{"key":"2385_CR21","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1245\/s10434-015-5013-2","volume":"23","author":"SP Haugvik","year":"2016","unstructured":"Haugvik SP, Janson ET, \u00d6sterlund P, et al. Surgical treatment as a principle for patients with high-grade pancreatic neuroendocrine carcinoma: a Nordic multicenter comparative study. Ann Surg Oncol. 2016;23:1721\u20138.","journal-title":"Ann Surg Oncol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-026-02385-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-026-02385-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-026-02385-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:43:22Z","timestamp":1791377002000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-026-02385-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,21]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2385"],"URL":"https:\/\/doi.org\/10.1007\/s12328-026-02385-2","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,21]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study followed the provisions of the 1964 Declaration of Helsinki, and patient anonymity was maintained.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from the patient\u2019s family for inclusion in the study.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}